Stream 1: Health Economics & Innovation

[1] Evidence to Inform Biopharmaceutical Policy: Call for Research on the Impact of Public Policies on Investment in Drug Development (with K. Axelsen and S. Ezell) [Health Affairs Scholar]

[2] Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients in the English National Health Service (working paper, with J. Buchanan, J. Buckell, and S. Wordsworth)

[3] Measuring Biopharmaceutical Innovation: A Proposed Rubric (working paper, under review at Nature Reviews Drug Discovery, with S. Kang, F. David, and S. Chang)

[4] Innovation in the Biopharmaceutical Industry: Slowing Down or Shifting Focus? (working paper, with S. Kang)

Stream 2: Economics of Science & AI

[1] Storm Crowds: Evidence from Zooniverse on Crowd Contribution Design (with J. Gans) [Research Policy]

[2] What Matters in Funding: The Value of Research Coherence and Alignment in Evaluators’ Decisions (working paper, status: R&R at Journal of Economics & Management Strategy, with C. Ayoubi, M. Pezzoni, and F. Visentin)

[3] Dali or DALL-E? Popper or …? The Implications of Emerging Generative AI for the Future of Creative Work (working paper, with P. Khashabi)

[4] Catalysts of Discovery: How Technologies are Shaping the Future of Science and Innovation (forthcoming book, with F. Teodoridis)